Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 5,500.00
-10.00 (-0.18%)
At close: Jun 4, 2026
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 131.73 billion as of June 3, 2026. Its market cap has increased by 2.80% in one year.
Market Cap
131.73B
Enterprise Value
264.80B
Revenue
269.64B
Ranking
n/a
PE Ratio
379.18
Stock Price
5,500.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 131.73B, a decrease of -83.91%. That is a compound annual growth rate of -15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 131.73B | -4.51% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hana Pharm | 161.91B |
| Jeil Pharmaceutical Co.,Ltd | 160.14B |
| Daihan Pharmaceutical | 154.94B |
| Dongwha Pharm.Co.,Ltd | 151.62B |
| AptaBio Therapeutics | 150.58B |
| Samil Pharmaceutical Co.,Ltd | 150.52B |
| Ilyang Pharmaceutical Co.,Ltd | 149.14B |
| SAMSUNG PHARM. Co., LTD. | 135.72B |